Luis Nunes
Assistent med doktoranduppgifter vid Institutionen för immunologi, genetik och patologi; Forskningsprogram: Cancerprecisionsmedicin; Forskargrupp Tobias Sjöblom
- Mobiltelefon:
- 070-425 03 01
- E-post:
- luis.nunes@igp.uu.se
- Besöksadress:
- Dag Hammarskjölds väg 20
751 37 Uppsala - Postadress:
- Rudbecklaboratoriet
751 85 Uppsala
- ORCID:
- 0000-0002-3391-1607
Mer information visas för dig som medarbetare om du loggar in.
Publikationer
Senaste publikationer
- Sensitive and Specific Analyses of Colorectal Cancer Recurrence through Multiplex superRCA Mutation Detection in Blood Plasma (2024)
- Atypical (non‐V600E) BRAF mutations in metastatic colorectal cancer in population and real‐world cohorts (2024)
- Recurring EPHB1 mutations in human cancers alter receptor signalling and compartmentalisation of colorectal cancer cells (2023)
- Prognostic and Predictive Somatic Mutations in Colorectal Cancer (2023)
- Prognostic role of tumour-infiltrating lymphocytes and macrophages in relation to MSI, CDX2 and BRAF status (2022)
Alla publikationer
Artiklar
- Sensitive and Specific Analyses of Colorectal Cancer Recurrence through Multiplex superRCA Mutation Detection in Blood Plasma (2024)
- Atypical (non‐V600E) BRAF mutations in metastatic colorectal cancer in population and real‐world cohorts (2024)
- Recurring EPHB1 mutations in human cancers alter receptor signalling and compartmentalisation of colorectal cancer cells (2023)
- Prognostic role of tumour-infiltrating lymphocytes and macrophages in relation to MSI, CDX2 and BRAF status (2022)
- KRAS-G12C Mutation in One Real-Life and Three Population-Based Nordic Cohorts of Metastatic Colorectal Cancer (2022)
- Molecular characterization of a large unselected cohort of metastatic colorectal cancers in relation to primary tumor location, rare metastatic sites and prognosis (2020)
- Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer
- Prognostic whole-genome and transcriptome signatures in colorectal cancers
- Primary tumor location, molecular alterations, treatment, and outcome in a population-based metastatic colorectal cancer cohort